KELKER PHARMA Trademark

Trademark Overview

On Sunday, May 5, 2024, a trademark application was filed for KELKER PHARMA with the United States Patent and Trademark Office. The USPTO has given the KELKER PHARMA trademark a serial number of 98534629. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, January 31, 2025. This trademark is owned by Kelker Pharma, Inc.. The KELKER PHARMA trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacturing of dietary supplements for humans
kelker pharma

General Information

Serial Number98534629
Word MarkKELKER PHARMA
Filing DateSunday, May 5, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, January 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCustom manufacturing of dietary supplements for humans
NOT AVAILABLE"PHARMA"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSunday, May 5, 2024
Primary Code040
First Use Anywhere DateWednesday, September 30, 2015
First Use In Commerce DateWednesday, September 30, 2015

Trademark Owner History

Party NameKelker Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHermosa Beach, CA 90254

Trademark Events

Event DateEvent Description
Monday, May 6, 2024NEW APPLICATION ENTERED
Friday, November 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2024ASSIGNED TO EXAMINER
Tuesday, November 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 19, 2024NON-FINAL ACTION E-MAILED
Tuesday, November 19, 2024NON-FINAL ACTION WRITTEN
Friday, January 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 31, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 5, 2025ASSIGNED TO EXAMINER

Related Keywords

pharma kelker humans supplements dietary manufacturing custom